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Abstract Abnormal patterns of DNA methylation are
observed in many diseases such as tumors and imprinting
disorders. Little is known about inter-individual and gender
speciWc variations. Here, we report on accurate and sensi-
tive quantitative measurements of methylation in DNA
from total blood in 96 healthy human males and 96 healthy
human females. Global methylation was estimated by
studying two repetitive DNA elements, namely Line-1 and
Alu repeats, while single loci were investigated for three
diVerentially methylated regions (DMRs) at PEG3,
NESP55 and H19 imprinted genes and two additional loci
at Xq28 (F8 gene) and at 19q13.4 (locus between PEG3
and ubiquitin speciWc protease 29). We observed inter-indi-
vidual correlations in the degree of methylation between
Alu and Line-1 repeats. Moreover, all studied CpGs showed
slightly higher methylation in males (P < 0.0003–0.0381),
with the exception of DMRs at imprinted genes
(P = 0.0342–0.9616) which were almost equally methyl-
ated in both sexes with only a small tendency towards
higher methylation in males. This observed diVerence could
be due to the process of X chromosome inactivation or
merely to the presence of an additional X chromosome in
female cells or could be a result of downstream eVects of
sex determination.
Introduction
DNA methylation constitutes an essential epigenetic mark
that inXuences a wide variety of biological processes
including gene expression, chromosomal stability, imprint-
ing and cellular diVerentiation. Abnormal methylation pat-
terns are associated with many human diseases such as
tumors and imprinting disorders. In addition to diseases,
inter-individual variations are also reported in healthy indi-
viduals at Alu repeats from whole blood DNA (Sandovici
et al. 2005). On the germ cell level, Flanagan et al. (2006)
reported on intra- and inter-individual epigenetic variation
in human sperm cells within promoter CpG islands, peri-
centromeric satellites repeats and even age related varia-
tions at several loci. Moreover, an international project
aiming at deciphering the methylation patterns in the
human genome, the “Human Epigenome Project”, provided
evidence of considerable inter-individual variations and of
tissue speciWc methylations (Rakyan et al. 2004).
In the context of the above mentioned variations in
healthy individuals, the eVect of gender has also been
widely discussed. However, conXicting data exist on sex-
dependent variations in levels of DNA methylation (Fuke
et al. 2004; Sandovici et al. 2005; Sarter et al. 2005; Eck-
hardt et al. 2006). The available data could be divided into
two groups depending on the type of analysis: the global
methylation content and the locus speciWc one.
The global content of 5-methyl cytosine could be accu-
rately measured by methods like total digestion of genomic
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tion by HPLC or by capillary electrophoresis (Kuo et al.
1980; Ramsahoye 2002; Stach et al. 2003; Fraga et al.
2005); data derived from such global methods show a ten-
dency towards higher methylation levels in males (Fuke
et al. 2004; Shimabukuro et al. 2006). These results are sur-
prising when considering that in female cells, the inactiva-
tion of one X chromosome is accompanied by methylation
of CpGs islands on the inactive X chromosome (Norris
et al. 1991). However, this controversy could be explained
by recent studies that showed hypomethylation on the inac-
tive X chromosome, especially at gene poor-regions, hyper-
methylation of CpG islands at gene rich regions while the
active X chromosome is hypermethylated in the body of
genes; but still Line-1 were found equally methylated on
both active and inactive X-chromosome in female somatic
cells (Hansen 2003; Weber et al. 2005; Wilson et al. 2006;
Hellman and Chess 2007).
While a small number of studies addressed the accurate
quantitative measurements of methylation at site speciWc
loci and its correlation with gender, not all results were con-
sistent. Sandovici et al. (2005) found no sex or age eVect on
the methylation of speciWc Alu repeats. Accordingly, Eck-
hardt et al. (2006), studying 2,524 diVerent loci on chromo-
some 6, 20 and 22 in 12 diVerent tissues and from 43
diVerent samples, could not Wnd any statistical diVerences
between male and female samples. However, the heteroge-
neity of the type of tissues and the small number of samples
make it diYcult to draw conclusive results on the sex or age
diVerence, especially when taking into consideration the
possibilities of inter-individual diVerences that could mask
small trends of sex or age dependent variations. On the
other hand, Sarter et al. (2005) observed statistically signiW-
cant diVerences between male and female lymphocytes.
Using a quantitative, sensitive assay (Eads et al. 2000) they
studied promoter regions of four diVerent autosomal loci
(MTHFR, CALCA, MGMT and ESR1) from a relatively
large number of individuals (134 males and 157 females).
The Wrst three loci showed higher methylation for males,
while ESR1 methylation levels were not gender dependent
as it was nearly unmethylated in both gender.
Furthermore, some indirect evidence also points to a
trend of lower levels of methylation in female cells. Zvetk-
ova et al. (2005) showed that ES cell lines derived from
female mice are hypomethylated in comparison to ES cell
lines from male mice. In addition, imprinted genes in pri-
mordial germ cells (PGC) were shown to be higher methyl-
ated in XY cells than in XX cells (Durcova-Hills et al.
2004, 2006). In these studies, the cells tested were in
embryogenic stages where both X chromosomes in XX
cells are still active. The authors proposed the presence of a
locus on the X chromosome that is responsible for this
lower methylation activity.
Therefore, to resolve this controversial issue, in this
study we addressed the question whether gender speciWc
diVerences exist in human somatic cells at speciWc loci.
We analyzed homogenous samples derived from uncul-
tured blood cells originated from matched age individuals
(about 24-year old; 96 males and 96 females). The regions
studied include two repetitive elements Alu and Line-1 that
cover the whole genome, three imprinted loci PEG3,
NESP55 and H19 and two single loci gene: F8 at Xq28 and
a CpG rich region between paternally expressed gene 3
and ubiquitin speciWc protease 29 at second exon of a theo-
retical 4 exons gene at 19q13.4 (Djuric et al. 2006). The
two single loci at Xq28 and 19q13.4 were chosen based on
our previous knowledge that these two regions are not
fully methylated, are mosaic in their patterns of methyla-
tion and show some inter-individual variations. In addi-
tion, we studied global methylation levels at CCGG
sequences by the LUMA method (Karimi et al. 2006). As a
result of this study, we report the novel observations that
repetitive elements, namely Line-1 and Alu repeats, and the
two single loci showed a slight but clear tendency and sta-
tistically signiWcant bias towards higher methylation in
males while a bias towards higher methylation in males at
imprinted loci was observed, but this was not statistically
signiWcant. Moreover, clear inter-individual associations
in the level of methylation between Alu and Line-1 repeats
were observed.
Materials and methods
DNA from blood donors
Blood samples collected from 96 healthy women and 96
healthy men were obtained from blood donors at the Insti-
tute of Experimental Hematology and Transfusion Medi-
cine, Bonn, Germany. DNA was extracted by a salting out
method according to standard procedures. The individuals
were matched for their age with averages of males and
females of 24.80 § 3.37 and 24.30 § 3.54, respectively
(Supplementary Table 1). The Ethics Committee of the
Medical Faculty at the University of Bonn approved the use
of the above-mentioned material for research purposes
(Ethics Committee approval Nr. 106/05).
Global genomic methylation contents by the LUMA 
method
Luminescence methylation assay (LUMA) was essentially
performed as previously described by Karimi et al. (2006).
BrieXy, 500 ng of DNA to be measured was cleaved with
HpaII + EcoR1 or MspI + EcoR1 (5 U from each enzyme)
in two separate tubes. The total volume of reaction was123
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Next, 20 l annealing buVer (20 mM Tris–acetate, 2 mM
Mg–acetate pH 7.6) was added and samples were measured
in a PSQ96™MA pyrosequencing machine (Biotage AB,
Uppsala, Sweden). EcoR1 leaves 5-TTAA sticky ends on
the DNA that can be extended by As and Ts, while HpaII
and MspI leaves 5-GC that can be extended by Cs and Gs.
Therefore, the machine was programmed to Wrst add As,
then Gs and Cs. The Wrst would generate peaks correspond-
ing to the EcoRI digestion which can be used as internal
control for the quantity of DNA and the eYciency of cleav-
ages, while the second would give peaks corresponding to
all CCGG sites (for MspI) or for the unmethylated portion
of CCGG (for HpaII). Next, the percentage of methylated
CCGG sites was calculated according to the formula:
Meth% = [1 ¡ (peak HpaII/peak EcoR1)/(peak MspI/peak
EcoR1)] £ 100.
BisulWte modiWcation and PCRs
BisulWte treatment of the DNA was performed essentially
as previously described (El-Maarri et al. 2004). Primers
used in this study are listed in Supplementary Table 2.
Site-speciWc methylation by SIRPH analysis
The site-speciWc methylation measurements at selected
CpG sites were done by the SIRPH method as previously
described by El-Maarri et al. (2002), El-Maarri (2004).
SNuPE primers used in this study are given in Supplemen-
tary Table 2.
Pyrosequencing
The pyrosequencing analysis was performed according to
Tost et al. (2003). The PCRs were generated using the same
primers used in the bisulWte PCR (Supplementary Table 2)
with a biotin labeled reverse primer that is needed to gener-
ate single stranded DNA for analysis. The reactions were
performed using the Pyro Gold reagents from Biotage
(Uppsala, Sweden) on a PyroMark ID system. The primers
used for pyrosequencing are the same as SN1 (for H19,
PEG3 and NESP55) used by the SIRPH primer (Supple-
mentary Table 2).
Cloning of individual PCR products
Individual PCR products were puriWed to remove unreacted
primers and excess dNTPs by column puriWcation using the
QIAquick PCR puriWcation kit (catalogue number: 28106;
QIAGEN, Hilden, Germany). The puriWed PCR product
was then ligated to a pGEM-T cloning vector (pGEM-T
Vector System 1, catalogue number A3600, Promega,
Mannheim, Germany). Individual positive clones were
isolated by PCR using M13 primers and sequenced using
standard protocols.
Statistical analysis
Methylation values were determined for the Wrst group of
96 males and 96 females in a two 96-well plate format, and
for the second group of 48 males and 48 females in one 96-
well plate. In order to exclude bias due to experimental var-
iation, for each methylation variable y, the measurement
values yi of y were corrected for trend within each gender
group as follows: the samples were assigned natural num-
bers according to the order in which their methylation val-
ues were determined. These ordinals were treated as a
variable x. For each methylation variable y, we computed
the linear regression of y on x, separately for males and
females. The measurements yi of the variable y were
adjusted according to yi,new = yavg + diVyi,y(xi). Here, yavg is
the average of the measurements yi of variable y and
diVyi,x(yi) is the diVerence between the observed value yi to
the value y(xi) that is expected according to the trend
regression line y(x). This procedure guarantees that there is
no linear trend within the adjusted measurements of each
subgroup. Finally, the complete sample was reconstructed
from the corrected measurements of the male and female
subgroup.
From the adjusted data sample, Pearson correlation
coeYcients ry,z were computed for all pairs (y,z) of methyl-
ation variables and for all pairs (y, sex) using the function
proc corr from the SAS software package (SAS for Win-
dows, version 9.1.; SAS Institute Inc., Cary, NC, USA;
http://www.sas.com). This procedure was also used to com-
pute P values for the null hypotheses H0: r,yz = 0 and H0:
ry,sex = 0. In this way, the signiWcance of the correlation
coeYcients was assessed. We applied a Bonferroni correc-
tion of 128, which is the number of considered pairs. Thus,
uncorrected P values below 0.05/128 = 0.00039 were con-
sidered to be signiWcant at size 0.05 after correction for
multiple testing.
Statistical signiWcance of sequencing data was assessed
with the non-parametric Wilcoxon–Mann–Whitney test.
The analysis was based on SAS software package using the
function “proc npar1way”. For each of the Wve sequencing
regions (NESP55, PEG3, H19, F8, CpG island at 19q13.4),
the number sites with positive methylation measurements
per clone was computed. We tested the hypothesis of no
diVerence in degree of methylation between sex groups. In
case of imprinted regions NESP55, PEG3, and H19, clones
were divided in two classes, strong methylation (more than
90% of positive methylated sites) and low methylation
(rest, which shows less than 10% of positive methylated
sites).123
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In this study, we investigated locus speciWc methylation at
selected CpGs at repetitive Alu and Line-1 repeats, at
three DMRs associated with imprinted loci PEG3 (mater-
nal alleles methylated), NESP55 and H19 (paternal alleles
methylated) and at two single loci, in F8 and at a locus on
chromosome 19q13.4 between paternally expressed gene
3 and ubiquitin speciWc protease 29 at second exon of a
theoretical 4 exons gene. Methylation levels at selected
CpG sites were quantitatively evaluated by treating the
DNA with bisulWte and subsequent quantiWcation of the
PCR for methylation by either the SNuPE combined with
ion pair reverse phase HPLC (SIRPH) assay or by the
pyrosequencing technique. Both methods are highly
reproducible and able to accurately detect diVerences in
methylation (El-Maarri et al. 2002; El-Maarri 2004; Tost
et al. 2003).
Repetitive elements
The investigated repetitive elements were Line-1 and Alu
repeats. We did not amplify speciWc repeats at speciWc
genomic loci but used degenerate primers that will amplify
diVerent subclasses of repeats dispersed over the whole
genome; this was proven by sequencing of individual
clones of cloned PCR products, no two clones were the
same, this indicate the variability of the content of the PCR
product that cover ampliWed region over all genome
(Supplementary Table 3). Although such an assay is not
speciWc for a given genomic locus, it provides a global
estimate of methylation at the repeats under investigation.
Using the SIRPH protocol we measured methylation at two
CpG sites, SN2 and SN4, in the Alu consensus sequence,
while four diVerent CpG sites, SN1, SN3, SN8 and SN9,
were analyzed from Line-1 repeat sequence (Supplemen-
tary Table 1). All sites from these groups of healthy total
blood DNA showed higher methylation levels for male
samples than for female samples. The lowest methylation
diVerence was 0.30% for Alu SN4 (P = 0.0003), while the
highest diVerence was 5.80% for Line-1 SN9 (P < 0.0003)
(Table 1). The diVerences in methylation were statistically
signiWcant at all sites.
Imprinted diVerentially methylated regions
Two CpGs were investigated at NESP55 and one CpG for
each H19 and NESP55 (Supplementary Table 1). All four
loci showed some small bias toward higher methylation
levels in males, however, none of them reached statistical
signiWcance (P values ranges from 0.0342 for PEG3 SN1 to
0.9616 for NESP55 SN4) (Table 1). At the H19 locus we
observed some limited variations in the methylation levels
that Xuctuated between 35 and 48%.
Single loci
Two single loci were investigated in this study: a non-clus-
tered group of CpG sites located in the exon 14 of the F8
gene at Xq28 and a CpGs cluster located between PEG3
and ubiquitin speciWc protease 29 at second exon of a theo-
retical 4 exons gene at 19q13.4. We had shown earlier that
Table 1 Mean methylation val-
ues of 96 healthy males and 96 
healthy females at NESP55, 
PEG3, H19, F8, two CpGs at 
19q13.4, Alu repeats and Line-1 
repeats
Region Primer CpG # Males Females Mean 
diV
P values Holm 
adjusted P
Mean SD Mean SD
NESP55 SN1 3 35.26 2.38 34.84 2.96 0.42 0.283492 0.850000
SN4 29 45.02 4.15 44.99 4.80 0.03 0.961617 0.962000
PEG3 SN1 12 30.28 3.22 29.35 2.79 0.93 0.034288 0.171000
H19 SN1 4 42.19 2.90 41.82 2.88 0.37 0.380858 0.762000
F8 SN2 4 89.00 3.80 85.05 4.75 3.95 <0.000001 <0.000001
SN1 7 90.94 2.92 88.26 4.68 2.68 0.000006 0.000045
SN3 8 84.96 6.43 68.77 8.46 16.19 <0.000001 <0.000001
19q3.4 SN2 8 68.42 7.77 62.97 7.25 5.45 0.000001 0.000013
SN3 11 62.16 10.18 59.71 4.88 2.45 0.038188 0.153000
ALU SN2 16 37.29 1.18 35.43 1.19 1.86 <0.000001 <0.000001
SN4 10 32.50 0.48 32.20 0.63 0.30 0.000303 0.002120
L1 SN9 1 58.82 2.06 53.02 2.00 5.80 <0.000001 <0.000001
SN1 13 58.11 1.60 56.50 1.14 1.61 <0.000001 <0.000001
SN8 15 73.69 3.63 69.19 4.62 4.50 <0.000001 <0.000001
SN3 24 61.76 1.60 60.04 1.32 1.72 <0.000001 <0.000001
LUMA – – 0.71 0.08 0.73 0.07 ¡0.03 0.023650 0.142000
These values are measured by 
the SIRPH protocol. The values 
obtained by LUMA are shown in 
the last row. The CpG number in 
the ampliWed region is given in 
the third column. Statistical sig-
niWcance between the male/fe-
male mean diVerences are 
measured by t-test and P values 
are given in the last column123
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Wrst locus is not known to be subject for methylation upon
X chromosome inactivation as it is already methylated in
about 85% in both males and females. The locus at 19q13.4
is lying close to known imprinted region containing the
PEG3/ZIM2 imprinted genes and since the extent of this
imprinted domain in human is not known yet, this locus
may be regarded as being present in a potentially extensive
imprinted domain. Three CpGs were investigated at the
former, while two were investigated at the latter locus
(Supplementary Table 1). All Wve CpGs showed a bias
towards higher methylation levels in males with diVerences
of methylation ranging from 2.45% for SN3 at 19q13.4
(P = 0.0381) to 16.19% for SN3 at F8 (P < 0.0003)
(Table 1). Four of the Wve sites were found to be statisti-
cally signiWcant for the diVerences between male and
female samples, while SN3 at 19q13.4 was not signiWcant
(P = 0.0381).
ConWrmation of diVerences in a subgroup of 48 males 
and 48 females
In order to assess whether the above mentioned observed
gender speciWc diVerences are due to a random inter-indi-
vidual variation, we repeated the bisulWte treatment and the
methylation measurements by pyrosequencing in a sub-
group of 48 males and 48 females (from the same healthy
blood donors) for F8 and Line-1 repeats as well as NESP55,
PEG3, and H19 imprinted regions (Supplementary Table 4)
(Tost et al. 2003). Here, most loci again showed higher
methylation levels in males (Table 2). The signiWcance of
the diVerences at Line-1 was higher in the Wrst cohort of the
96 males and 96 females than in the subgroup of 48 males
and 48 females. This was specially noticeable at the second
measured position and even more at the third; the reason for
this could be due to the highly variable sequences ampliWed
by our PCR assay and the limitation in the pyrosequencing
to analyze only the input sequence that we specify, in this
case corresponding to the consensus sequence. The CpGs
sites that are preceded directly by stretches of Ts were
excluded from the analysis due to inaccuracy of correct
estimation of methylation due to merging the values corre-
sponding to the stretches of Ts with the T corresponding to
unmethylated portion of DNA.
Methylation levels at CpG sites that were studied by
both pyrosequencing and SIRPH methods did not show
concordance in the mean levels of methylations (Tables 1,
2). Although both methods are based on single nucleotide
primer extension assays however, the experimental condi-
tions in both assays are not the same and this explain the
observed diVerences in the values. For example the pyrose-
quencing requires the isolation of single stranded biotin
labeled PCR product, while the SIRPH use directly the
bisulWte PCR product, the reaction temperature in the
pyrosequencing is 28°C and involve no cycling while the
SIRPH use 70 cycles of annealing at 40°C and extension at
52°C.
Sequencing of individual clones
To visualize the nature of these gender diVerences, we
cloned and sequenced large numbers of clones from most
studied regions (NESP55, PEG3, H19, F8, Line-1, and
CpG Island at 19q13.4) from an average of eight females
and eight males. The sequencing clones show largely
mosaic patterns at the non-imprinted regions, while
imprinted regions show a clear division between largely
methylated and largely unmethylated clones with sporadic
methylated CpGs at the non-methylated clones and spo-
radic unmethylated CpGs at the methylated clones (Fig. 1).
Table 2 Mean methylation val-
ues of 48 healthy males and 48 
healthy females at NESP55, 
PEG3, H19, F8, Line-1 repeats
Region CpG # Males Females Mean
diV
P values Holm 
adjusted P
Mean SD Mean SD
NESP55 3 44.61 4.25 44.12 4.54 0.48 0.595043 1.000000
5 58.24 2.32 57.64 2.22 0.60 0.204764 1.000000
6 56.33 5.29 55.69 5.19 0.65 0.551644 1.000000
PEG3 12 44.90 5.49 44.57 5.36 0.32 0.781735 1.000000
14 47.76 4.91 47.17 5.14 0.59 0.585872 1.000000
H19 4 49.16 2.65 48.63 3.07 0.53 0.385526 1.000000
6 50.37 2.3 50.31 2.31 0.05 0.911652 1.000000
8 52.29 2.56 52.21 2.93 0.09 0.883743 1.000000
F8 7 64.65 3.12 61.21 4.13 3.45 0.000096 0.001050
8 68.25 2.99 63.96 2.86 4.29 0.000000 0.000000
L1_SNP9 15 37.20 3.28 32.88 3.99 4.32 0.000083 0.000992
17 53.54 5.11 48.43 5.43 5.11 0.001160 0.011600
18 23.29 3.32 22.08 2.29 1.22 0.166757 1.000000
These samples are the Wrst 48 
groups of samples reported also 
in Table 1, however, the data 
were measured from completely 
diVerent PCR products and by 
pyrosequencing techniques. Sta-
tistical signiWcance between the 
male/female mean diVerences 
are measured by t-test and P val-
ues are given in the last column123
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than 99% of Cs at non CpG was converted to Ts. The aver-
age methylation diVerence showed a bias towards higher
methylation levels in males at most loci; however, not all
loci reach statistical signiWcance. At F8 we observed a male
female diVerence of 4.47% (P < 0.05) and at the CpG
island at 19q13.4 a mean diVerences of 1.97%
(P = 0.7540). Regarding the unmethylated clones of
imprinted diVerentially methylated regions (DMRs) of
NESP55 and PEG3, we observed higher unspeciWc methyl-
ation averages in males with mean diVerences of 0.39%
(P = 0.8818) and 5.16% (P < 0.05), respectively (Fig. 1).
Methylated clones were also, on average, higher methyl-
ated in males with mean diVerences of 1.01% (P < 0.05)
and 1.54% (P = 0.2651) for NESP55 and PEG3, respec-
tively (Fig. 1). At H19, both the largely methylated group
of clones (P = 0.2532) and the largely unmethylated group
of clones (P = 0.9943) showed slightly lower methylation
Fig. 1 Summary of the bisulWte sequencing results for males and fe-
males in two single loci (at Xq28 and 19q13.4) and three imprinted loci
(NESP55, PEG3, H19). PCR products from eight diVerent individuals
for every gender were pooled together, cloned into a TA cloning vector
and large numbers of individual clones were sequenced. Individual
CpGs are represented as Wlled and open circles for methylated and un-
methylated, respectively. Average methylation of all CpGs in all se-
quenced clones in a given region is provided under each group of
clones, positions with known polymorphisms like CpGs 16 and 34 in
PEG3 and CpG 7 in H19 were excluded from the calculated average.
For imprinted regions, the methylated and unmethylated clones are
grouped separately assuming that one parental alleles are largely meth-
ylated while the others are largely unmethylated (P paternal alleles;
M maternal alleles). The positions of the CpGs studied by SIRPH
reaction are indicated by vertical arrows, the SIRPH primer used and
the number of CpGs analyzed is corresponding to Table 1 
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cloned and individual clones were sequenced. As Line-1
repeats showed great variety in the genome due to muta-
genesis of CpG sites, no two clones were identical. This
reXects the great variety of the ampliWed target that is not
covering a speciWc locus but rather the whole genome. To
calculate the average methylation, we considered sites that
are either CG or TG at a given CpG site, from a total of 82
male and 106 female clones. The average methylations
were 78.74 and 76.56% for males and females, respectively
(Supplementary Table 3) clearly indicating a 2.18% higher
methylation in males. Thus the sequencing results goes in
line with the observed trends that we see in our quantitative
results and were not unexpected.
Total methylation measurements by LUMA method
The luminescent methylation assay, or LUMA, can esti-
mate the methylation levels in a given DNA sample at
CCGG sites. LUMA analysis did reveal a slightly exces-
sive, but not statistically signiWcant higher methylation in
females (Supplementary Table 1) (Table 1). However, it is
important to mention that this assay, although global, is still
limited by the CCGG sequence representing only a small
fraction of all CpG sites. Hence, it does not represent the
whole genome.
Inter-individual correlation between Alu and Line-1 repeats
As detailed methylation values at diVerent loci were gener-
ated during this study, we investigated the correlation with
methylation levels or trends between these loci (Table 3). A
signiWcant association was observed between two repetitive
elements: Line-1 and Alu (Alu SN2 and Line-1 SN1, SN3
and SN8) (Fig. 2; Table 3). The correlations were not
restricted to one sex. Strong correlation was observed
between diVerent CpGs in the same repeat, i.e. between Alu
SN2 and Alu SN4 and between the 4 CpGs at Line-1
repeats, while less signiWcance was observed between Alu
SN4 and diVerent CpG sites at Line-1. No signiWcant corre-
lation was shown with the LUMA methylation measure-
ments, which is partially due to the fact that CCGG sites
tested by the LUMA assay are not represented at the CpGs
studied in the repetitive elements by the SIRPH reaction.
Discussion
About 0.8–1% of the human DNA consists of 5-methyl-
cytosine. This level can vary slightly from one tissue to
another with placenta having the lowest level, while brain
tissue harbors the highest levels (Gama-Sosa et al. 1983). It
is also widely accepted that a considerable portion of
tumors are accompanied by a decrease in the total content
of 5-methyl cytosine (Ehrlich 2006). However, it remains
uncertain whether methylation levels, diVer in the sexes as
diVerent studies report diVerent Wndings (Fuke et al. 2004;
Sandovici et al. 2005; Sarter et al. 2005; Eckhardt et al.
2006). The variability of the conclusions in diVerent studies
could be partially due to the diVerences in methods used,
tissue samples and DNA loci studied in each report. For
example, a small number of studied individuals could mask
the sex dependent diVerences due to small inter-individual
as well as assay variability. The advantage of our study is
the homogeneity of the samples used in term of matching
age group, the large number of samples and the “uncul-
Table 3 Summary table showing the signiWcant correlation coeYcient (Pearson correlation coeYcient) of methylation at Line-1 and Alu diVerent
CpGs
The methylation values at diVerent CpG sites at Alu and CpG sites at Line-1 were measured from two bisulWte PCR products. Data are derived
from the 96 males and 96 females with methylation values measured by SIRPH protocol. P values are given below each correlation coeYcient.
The Wrst column for a given region is for females (indicated by F), followed by males (indicated by M). Highly signiWcant correlations are in bold
Alu SN2 Alu SN4 L1 SN1 L1 SN3 L1 SN9 L1 SN8
F M F M F M F M F M F M
Alu SN4 0.52485
<0.0001
0.5675
<0.0001
L1 SN1 0.59614
<0.0001
0.51937
<0.0001
0.35539
0.0005
0.22735
0.0284
L1 SN3 0.63965
<0.0001
0.47274
<0.0001
0.35856
0.0005
0.21712
0.0366
0.6842
<0.0001
0.8948
<0.0001
L1 SN9 0.59756
<0.0001
0.35338
0.005
0.36033
0.0004
0.21293
0.0416
0.5077
<0.0001
0.8297
<0.0001
0.7794
<0.0001
0.8115
<0.0001
L1 SN8 0.1523
0.1615
0.10421
0.3256
-0.00324
0.9763
0.12194
0.2496
0.3094
0.004
0.5144
<0.0001
0.5165
<0.0001
0.5928
<0.0001
0.419
<0.0001
0.6949
<0.0001
LUMA ¡0.14303
0.1691
¡0.1194
0.2543
¡0.20976
0.0413
¡0.09339
0.3733
¡0.06096
0.5638
¡0.13876
0.1871
¡0.14899
0.1587
¡0.07806
0.4596
¡0.10648
0.3097
¡0.12753
0.2283
¡0.03951
0.7163
¡0.18707
0.0775123
512 Hum Genet (2007) 122:505–514tured” source of DNA. Our results show slight but clear
diVerences between both groups of male and female sam-
ples. At most loci, the average methylation in males was
higher, however the degree of diVerences was not the same
at all loci. This possibly reXects a sequence-dependent vari-
ation as a pronounced Xanking sequence preference of
Dnmt3a and Dnmt3b was previously detected (Handa and
Jeltsch 2005).
Possible candidates responsible for the observed sex spe-
ciWc diVerences are the sex chromosomes. The presence of
two X chromosomes in females could be acting in two
directions: (1) a factor/gene on the X chromosome that is
inducing a hypo-methylation phenotype; however, during
X chromosome inactivation, this factor is reduced but not
to the same level as in males due to leaky expression; or (2)
The process of X chromosome inactivation by itself
requires “considerable epigenetic resources” to inactivate
one complete X chromosome resulting in less resources to
properly methylate autosomal loci. This was suggested by
Blewitt et al. (2005). Yet, no direct evidence for such a sce-
nario is available.
Recent reports showed that CpGs in the body of genes
(in contrast to CpG islands at promoter region) are more
methylated on the active X chromosome (Hellman and
Chess 2005; Weber et al. 2005). This would partially
explain the higher male methylation we observed at the
studied F8 CpGs in exon 14. However, since the applied
micro array approaches that were used in the above studies
are qualitative rather than quantitative estimation of meth-
ylation levels, a direct comparison to our data is not possi-
ble. Yet, the higher male methylation at repetitive elements
(Line-1 and Alu) could also be inXuenced by the diVerential
distribution of these repeats on the XY chromosomes
(Abrusan and Krambeck 2006), but Line-1 sequences were
found to be equally methylated on both active and inactive
X chromosomes in female somatic cells (Hansen 2003),
therefore the diVerence distribution of these interspersed
sequences on the sex chromosomes may not explain the
observed methylation diVerences. What also supports this
view is the lack of hypomethylated Line-1 clones from the
females sequenced clones (Supplementary Table 3).
But why DMRs of imprinted genes are not signiWcantly
aVected? We can hypothesize that any factor inXuencing
the gender speciWc diVerence in methylation levels (if any)
acts during development or during the cell cycle at a time
when methylation or the epigenetic marks at imprinted
regions are already established. Another possibility is that
the position of the imprinted genes in some speciWc chro-
mosomal domains allows little variations in methylation.
Such position eVect was previously observed for inter-
individual diVerences at Alu repeats (Sandovici et al.
2005).
Fig. 2 Methylation values at 
one CpG site in Alu repeats 
(SN2) plotted against methyla-
tion values at one CpG site in 
Line-1 repeats (SN1), a males 
and b females. 96 males and 96 
females are represented; each 
dot represents the values for one 
healthy individual. A trend line 
is also shown together with 
regression coeYcient. The same 
data are also represented in 
Table 2 column 1 and 2 and 
row 2
Males AluSN2 Vs L1SN1 y = 0.7064x + 31.786R2 = 0.2697
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Females AluSN2 Vs L1SN1 y = 0.5751x + 36.136R2 = 0.3554
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Hum Genet (2007) 122:505–514 513In our study, we also observed a strong correlation in the
level of methylation between CpG sites at Line-1 and Alu
repeats. Such observations have been reported in tumor
samples (Weisenberger et al. 2005). Still ours is the Wrst
report on such small variations in a large number of healthy
samples. These novel observations are highly suggestive
for genetic and/or environmental inXuences that could
include dietary eVects. The level of methylation was shown
to be aVected by the levels of methyl donor supplementa-
tion in the diet (e.g. folic acid and vitamin B12). This was
clearly shown during early embryogenesis at the agouti and
at the axin fused loci in mice (WolV et al. 1998; Waterland
et al. 2006). Moreover, exposure to environmental pollu-
tants, e.g., benzene, was also shown to induce slight but
signiWcant hypomethylation at LINE-1 and AluI repeats in
humans (Bollati et al. 2007). The DNA samples we used
were derived from young and healthy individuals who
adhered to an adequate diet and whom we do not expect to
have deWciencies in methyl-donor group uptake. However,
neither this nor any other environmental factor could be
totally excluded. A most probable scenario is that environ-
mental as well as genetic factors play a role in modulating
methylation levels in humans.
In summary, we are reporting on two novel observations.
The Wrst one establishes a gender speciWc diVerences in
methylation levels with males being slightly but signiW-
cantly higher methylated at the studied CpG sites with the
exception of imprinted genes. The second observation indi-
cates a strong inter-individual correlation in the level of
methylation at Alu and Line-1 repeats. The reasons behind
both of these phenomena are not fully explored. Further
studies are required to address possible factors that could be
responsible.
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